Korea has a reputation as a place where stem cell treatment is available without the restrictions found elsewhere. That reputation is half right, and the half that is wrong is the part that matters when something goes wrong.
Two categories, very different rules
Everything turns on how much the cells are manipulated between coming out of your body and going back in.
| What is done | Regulatory status | Typical setting |
|---|---|---|
| Fat harvested, mechanically separated, reinjected in the same operation | Practice of medicine | Clinic operating room |
| Cells cultured or expanded over days or weeks | Regulated as a biological drug, MFDS approval required | Licensed manufacturer |
| Cells from a donor rather than the patient | Regulated as a biological drug, MFDS approval required | Licensed manufacturer |
The first category is what most Korean aesthetic clinics offer when they advertise SVF or stem cell liposuction. It is legal, it happens inside one operation, and it does not require product approval because nothing is being manufactured.
The second and third categories are pharmaceutical products. Korea approved Cartistem, an allogeneic umbilical cord blood derived treatment for knee cartilage defects, in 2012, and it remains among a very small number of approved cell therapy products worldwide. That approval took years of clinical trial data.
Why the distinction protects you
An approved product carries manufacturing standards, documented composition, and a regulator that can act. Same-operation processing carries none of that; it relies entirely on the clinic's own technique and equipment.
That is not an argument against it. The autologous same-operation route has a genuine evidence base for one specific use: improving the survival of fat grafts. A 2024 multicentre randomised controlled trial found better graft survival in SVF-enriched facial fat transfer than in controls.
It is an argument for knowing which one you are receiving, and for treating claims that stretch beyond graft survival with more scepticism than the clinic will encourage.
Questions that separate serious clinics from the rest
Ask whether the processing is mechanical or enzymatic. Enzymatic digestion produces a different regulatory profile in many jurisdictions and is worth understanding before you consent.
Ask whether the laboratory is on the premises. A clinic with its own cell laboratory can describe its equipment, its process and who runs it. One that ships samples out is dependent on a third party it may not name.
Ask what the cells are being added to, and what happens if they are not added. If the answer to the second question is that the result would be the same, you have learned what you needed to know.
Ask for the expected outcome in a measurable form: what proportion of graft volume is expected to survive at six months, and whether the clinic measures it or judges from photographs.
What this looks like in practice
A well-run version of this looks unglamorous. Fat comes out during liposuction that you were having anyway. Part of it is processed while you are still in the room. The concentrate is mixed into fat being grafted to the face or elsewhere in the same operation. Nothing is stored, cultured or shipped.
Some larger Korean practices have built dedicated cell laboratories for this and have had them formally recognised as research departments. That recognition is about research infrastructure rather than product approval, and it is worth understanding as the former rather than the latter.
What to be careful about
Treatments marketed as stem cell therapy for conditions unrelated to the operation you are having deserve particular care. Joint treatment, neurological indications and general anti-ageing programmes are where the gap between marketing language and evidence is widest, and where the regulatory category is most likely to have been blurred.
If you are travelling specifically for cell therapy rather than for surgery that happens to include it, ask for the approval status in writing before you book anything.
Frequently asked questions
Is stem cell treatment legal for foreign patients in Korea?
Same-operation processing of your own fat is legal and available to anyone. Cultured or donor-derived cell products require Ministry of Food and Drug Safety approval, and the small number of approved products are used for defined indications rather than general rejuvenation.
What is the difference between SVF and cultured stem cells?
SVF is a mixed cell concentrate separated from your own fat during the operation, containing adipose-derived stem cells among other cell types. Cultured stem cells are grown in a laboratory over days or weeks, which places them in the regulated drug category.
Does an in-house laboratory mean the treatment is approved?
No. An in-house laboratory means the clinic processes tissue itself rather than sending it out. Approval is a separate matter that attaches to manufactured products, not to procedures.
Which stem cell products are approved in Korea?
A small number, of which Cartistem, an allogeneic umbilical cord blood derived product for knee cartilage approved in 2012, is the best known. Approval is granted for specific indications supported by trial data.
What should I get in writing before treatment?
The regulatory category of what you are receiving, whether processing is mechanical or enzymatic, where it takes place, and the specific expected outcome with a timeframe. If any of these cannot be put in writing, that is your answer.
Sources
- Wufuer M, Choi TH, Najmiddinov B, Kim J, Choi J, et al. "Improving Facial Fat Graft Survival Using Stromal Vascular Fraction-Enriched Lipotransfer: A Multicenter Randomized Controlled Study." Plastic and Reconstructive Surgery, 2024. https://doi.org/10.1097/PRS.0000000000010625
- Vizoso FJ, Eiro N, Cid S, Schneider J, Perez-Fernandez R. "Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine." International Journal of Molecular Sciences, 2017. https://pubmed.ncbi.nlm.nih.gov/28841158/
Sources
- Wufuer M, Choi TH, Najmiddinov B, Kim J, Choi J, et al. "Improving Facial Fat Graft Survival Using Stromal Vascular Fraction-Enriched Lipotransfer: A Multicenter Randomized Controlled Study." Plastic and Reconstructive Surgery, 2024 https://doi.org/10.1097/PRS.0000000000010625
- Vizoso FJ, Eiro N, Cid S, Schneider J, Perez-Fernandez R. "Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine." International Journal of Molecular Sciences, 2017 https://pubmed.ncbi.nlm.nih.gov/28841158/